PUBLISHER: TechNavio | PRODUCT CODE: 1792231
PUBLISHER: TechNavio | PRODUCT CODE: 1792231
The global AI in inflammatory bowel disease market is forecasted to grow by USD 312.1 mn during 2024-2029, accelerating at a CAGR of 33.3% during the forecast period. The report on the global AI in inflammatory bowel disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative for enhanced diagnostic accuracy and personalized treatment pathways, rapid advancements in AI capabilities and proliferation of big data in healthcare, and surging investment and strategic industry collaborations fueling innovation.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 31.2% |
CAGR | 33.3% |
Incremental Value | $312.1 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's global AI in inflammatory bowel disease market is segmented as below:
By Disease Type
By Application
By End-user
By Geographical Landscape
This study identifies the evolution from diagnostic augmentation to predictive and prognostic intelligence as one of the prime reasons driving the global AI in inflammatory bowel disease market growth during the next few years. Also, ascendance of AI as engine for novel drug discovery and therapeutic development and strategic shift towards enterprise-level integration and demonstrable workflow efficiency will lead to sizable demand in the market.
The report on the global AI in inflammatory bowel disease market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global AI in inflammatory bowel disease market vendors that include AbbVie Inc., Bayer AG, BenevolentAI, Dova Health Intelligence Inc., F. Hoffmann La Roche Ltd., Insilico Medicine, International Business Machines Corp., Olympus Corp., Owkin Inc., PathAI Inc., Pfizer Inc., Siemens Healthineers AG, SingHealth Group., Takeda Pharmaceutical Co. Ltd., and Tempus Labs Inc.. Also, the global AI in inflammatory bowel disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: